Carlsmed, Inc. Common Stock (CARL) financials · rev $50.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Carlsmed, Inc. Common Stock (CARL) rev $50.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $50.5M | $27.2M |
| Cost of Revenue | $12.5M | $7.12M |
| Gross Profit | $38.0M | $20.0M |
| Operating Income | -$30.6M | -$24.1M |
| Net Income | -$29.6M | -$24.3M |
| EPS (Diluted) | -$2.12 | -$6.11 |
| Line | FY2025 |
|---|---|
| Total Assets | $130.1M |
| Current Assets | $126.7M |
| Cash & Equivalents | $85.8M |
| Inventory | $1.84M |
| PP&E | $1.49M |
| Total Liabilities | $31.3M |
| Current Liabilities | $14.3M |
| Long-term Debt | $15.3M |
| Total Debt | $15.3M† |
| Shareholders' Equity | $98.9M |
| Retained Earnings | -$100.8M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$29.0M | -$25.5M |
| CapEx | $642.0K | $180.0K |
| Investing Cash Flow | -$25.5M | -$180.0K |
| Financing Cash Flow | $100.1M | $58.5M |
| Free Cash Flow | -$29.6M | -$25.6M |
FAQ
What is CARL P/E and revenue?
Carlsmed, Inc. Common Stock (CARL) rev $50.5M.
What is CARL revenue?
Carlsmed, Inc. Common Stock last cached revenue is $50.5M (FY2025).
Is CARL profitable?
Carlsmed, Inc. Common Stock last cached net income is -$29.6M (FY2025).
What are CARL total assets?
Carlsmed, Inc. Common Stock last cached total assets are $130.1M (FY2025).
What is CARL free cash flow?
Carlsmed, Inc. Common Stock last cached free cash flow is -$29.6M (FY2025).
Not investment advice. Cached statements, not a live tape.